3 min. read
The System for Award Management, commonly referred to as SAM, is the official US government database housed at sam.gov. It consolidates federal exclusion records and identifies individuals and entities that are debarred, suspended, or otherwise ineligible to receive federal funds.
For ambulatory surgery centers, a SAM sanctions check verifies that owners, management, clinical leadership, staffing partners, and certain vendors are not prohibited from participating in federally funded programs. Because Medicare and Medicaid involve the receipt of federal funds, ASCs are expected to take reasonable steps to prevent excluded parties from benefiting directly or indirectly from reimbursement.
SAM is often associated with government contracting, but its relevance extends into healthcare operations. Federal oversight is focused on where federal dollars flow, not solely on contracting relationships.
SAM captures exclusions related to:
• Federal procurement and contracting
• Grants and financial assistance programs
• Suspension or debarment actions that may not yet appear on healthcare specific lists
An individual or entity may be listed in SAM but not reflected on the OIG List of Excluded Individuals and Entities at the same time.
Many ASC compliance programs are built around OIG screening alone. While OIG checks are required, they do not replace SAM screening. Treating the OIG list as comprehensive creates blind spots where federal exclusions still exist.
ASCs often view themselves as clinical providers rather than federal award recipients. This narrow framing leads to the incorrect assumption that SAM applies only to organizations with government contracts. Participation in Medicare and Medicaid constitutes receipt of federal funds, bringing SAM expectations into scope.
Responsibility for exclusion screening is frequently divided across departments or third parties. Common challenges include:
• Decentralized credentialing processes
• Reliance on third party staffing agencies
• Management companies handling parts of compliance
• No single owner accountable for exclusion oversight
In fragmented models, SAM is often omitted because it is perceived as duplicative or non clinical.
Some ASCs perform exclusion checks only at onboarding. Federal enforcement actions consistently emphasize the need for ongoing monitoring. Individuals and entities can become excluded after initial engagement, creating risk if checks are not repeated.
SAM is not designed for healthcare workflows. Challenges that cause deprioritization include:
• A non-intuitive interface
• Entity based listings instead of individual records
• Variations in legal names and aliases
• Lack of internal training on how to search effectively
Without clear policy and education, SAM screening is often overlooked.
The consequences of missed SAM exclusions extend beyond technical noncompliance. Potential impacts include:
• Identification of overpayments
• Civil monetary penalties
• False claims exposure
• Complications during payer or CMS audits
• Accreditation and reputational risk
These risks are cumulative and often surface during reviews that look back multiple years.
SAM sanctions checks are not a niche or optional compliance activity for ambulatory surgery centers. They are a practical reflection of how federal oversight expects providers to safeguard federal funds. When SAM is excluded from routine screening, ASCs create avoidable exposure that often surfaces only during audits, transactions, or enforcement reviews. Incorporating SAM into ongoing exclusion monitoring strengthens compliance programs, clarifies accountability, and reduces downstream risk. For ASCs focused on sustainability and defensibility, SAM screening is not an added burden but a baseline expectation.